SciELO - Scientific Electronic Library Online

vol.20Identification of two novel cytolysins from the hydrozoan Olindias sambaquiensis (Cnidaria)In vitroscreening and evaluation of antivenom phytochemicals from Azima tetracanthaLam. leaves against Bungarus caeruleusand Vipera russelli author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Journal of Venomous Animals and Toxins including Tropical Diseases

On-line version ISSN 1678-9199

J. Venom. Anim. Toxins incl. Trop. Dis vol.20  Botucatu  2014  Epub Mar 04, 2014 


Comparative analysis of the venom proteome of four important Malaysian snake species

Jaya Vejayan 1   *  

Too Lay Khoon 2  

Halijah Ibrahim 2  

1Faculty of IndustrialSciences and Technology, University Malaysia Pahang, Lebuhraya Tun Razak, Kuantan, Pahang Darul Makmur 26300, Malaysia

2Institute of Biological Sciences, University of Malaya, Kuala Lumpur 50603, Malaysia.



Naja kaouthia, Ophiophagus hannah, Bungarus fasciatus andCalloselasma rhodostoma are four venomous snakes indigenous to Malaysia. In the present study, their proteomic profile by two-dimensional gel electrophoresis (2-DE) have been separated and compared.


The 2-DE of venoms of the four species snake demonstrated complexity and obvious interspecies differences in proteome profiles. A total of 63 proteins were identified in the four species: C. rhodostoma -26, N. kaouthia - 16, O. hannah -15 and B. fasciatus - 6.


Despite the identifications of major proteins in the four snake species, a large number of protein spots from the 2-DE were unidentified even though the spots displayed high-quality MALDI-TOF-MS spectra. Those identified included phospholipase A2 proteins in all four venoms, long neurotoxins in both cobra species and the C. rhodostomavenom found with the most varied types of peptidases, i.e. metalloproteinase kistomin, halystase and L-amino acid oxidase.

Key words: Mass spectrometry; Snake venoms; Proteomics; Two-dimensional gel electrophoresis


In Malaysia, more specifically Peninsular Malaysia, a very rich snake fauna is present, consisting of approximately 141 known species of land and sea snakes. Of these, only 16 species of land snakes and all 21 sea snake species are venomous [1]. This study focused on four of these venomous species, namely Naja kaouthia, Ophiophagus hannah, Bungarus fasciatus and Calloselasma rhodostoma.The first three are of the Elapidae family while C. rhodostoma belongs to the Viperidae family. The venoms of N. kaouthia (monocled cobra, 1.5-2.0 meters long), O. hannah (king cobra, 3 to 4 meters long) and B. fasciatus (banded kraits, 1.6 meters long) are comprised mainly of neurotoxins [2,3]. Other potent basic polypeptides - such as cardiotoxin, cytotoxin and cobramines - are also found abundantly in the venoms of elapids. The short-tempered, quick-to-attack cobra is one of the most frightening; while kraits, though much more subdued, are also highly feared for their toxic, frequently death-causing bites. The venom of C. rhodostoma (Malayan pit viper, 0.6-1 meters long, previously known as Agkistrodon rhodostoma andAncis-trodon rhodostoma), is rich in peptidases that exhibit hemorrhagic activities and is capable of affecting blood coagulation, leading to a hemotoxic effect [4].

Since the early biochemical characterization of venoms, scientists have been unravelling the biological and pathological significance of their proteins and pep-tides. The advances in mass spectrometry (MS) for protein identification have revolutionized snake venom proteomics, shedding light into the global complexity of venom proteomes and, subsequently, their pathological activities. Using a multitude of proteomic approaches, venom proteomes have been analyzed in 55 snake genera [3]. The application of proteomics, including the use of two-dimensional gel electrophoresis (2-DE) and MS in studying venoms, has attracted considerable attention from researchers. The effective use of the 2-DE technique, coupled with MS, was first demonstrated in a study conducted by Fox and colleagues [5] in their comparative analysis of the venoms of Dispholidus typus, Crotalus atrox andBothrops jararaca. The correlation between genetic, ecological and phylogeny factors with intraspecific variations in the composition of theTrimer-esurus stejnegeri venom was investigated by Creer and colleagues [6] by employing matrix-assisted laser desorp-tion ionization-time-of-flight (MALDI-TOF)/MS and isoelectric-focusing (IEF) technologies. To further assess the extreme complexity of natural venoms, Li et al. [2] assessed the global venom proteomics profiles of Naja naja atra and Agkistrodon halysby a combination of four different approaches. Nawarak et al. [7], on the other hand, used 2-DE and MALDI-TOF MS to identify moderate- to high-molecular-mass glycoproteins in N. kaouthiavenom, which had been previously fractionated by binding with concanavalin A. These approaches have also been utilized for the characterization of novel proteins that are yet to be inserted into protein databases. For instance, MALDI-TOF MS has been employed to determine the molecular mass of purified proteins while 2-DE has been used to ascertain both the molecular weights as well as pI values of isolated proteins [8-10].

Numerous additional investigations into venom pro-teomes and subproteomes, using a wide array of prote-omic strategies, have provided novel insights into venom contents, their biological activities and the evolutionary relationships among snakes [3]. Nevertheless, as experienced by Li et al. [2], only 50% of the spots were confirmed to be venom proteins although approximately 80% of the gel spots from 2-DE displayed high-quality MALDI-TOF MS spectra. Scarcity of venom sequence databases for the analysis of MS data has posed a challenge to all snake venom proteomic studies. Proteomics tools provide enormous versatility in diverse applications, ranging from unravelling the complexity of varies venoms to potentially identifying the minute differences between very closely related organisms [11]. The current study aims to further underline the importance and challenges of proteomics in the study of snake venom by profiling the venom of four snake species indigenous to Malaysia.


Snake venoms

All venoms used were from common venomous snakes in Malaysia, obtained from a local vendor, Bukit Bintang Enterprise Sdn Bhd. The venoms were freeze-dried and stored at -20°C.

Protein content determination

The protein content in the four venoms was estimated using the dye-binding technique of Bradford [12] with bovine serum albumin (BSA) at 2.0 mg/mL concentration, purchased from Thermo Scientific.

Two-dimensional Gel electrophoresis (2-DE)

Eighteen-centimeter IPG strips (GE Healthcare, Sweden) with a linear pH range of 3 to 10 were rehydrated overnight with 340 μL of rehydration solution. After rehydration, the IPG strips were introduced with the venomous proteins (100 ug for silver staining and 300 ugfor Coomassie blue staining) via a sample-loading cup. Prior to this the venomous proteins had been dissolved in 100 μL of rehydration solution containing 8 M urea, 2% (w/v) CHAPS, 20 mM DTT (dithiothreitol), 0.5% (v/v) IPG buffer, 0.002% (w/v) Bromophenol blue. Electrofocus-ing was carried out at 30 kVh using IPGphor (GE Healthcare) at 20°C according to the manufacturer’s instruction. Before the second dimensional electrophoresis, the IPG strips were equilibrated by two equilibration steps: reduction buffer with 50 mM Tris/HCL, pH 8.8, 6 M urea, 30% (v/v) glycerol, 2% (w/v) SDS, a trace of Bromophenol blue and 1% (w/v) DTT on a rocking table for ten minutes; alkylation buffer with 50 mM Tris/HCL, pH 8.8, 6 M urea, 30% (v/v) glycerol, 2% (w/v) SDS, a trace of Bromophenol blue and 2.5% (w/v) iodoacetamide for an additional ten minutes. The equilibrated strips were loaded and run on 15% polyacrylamide Laemmli gels (26 cm x 20 cm) using the Ettan Dalt II system (GE Healthcare) with a programmable power control, initially 0.5 W per gel for 40 minutes, followed by 15 W per gel till the dye front reached the bottom of the gel. The separated gel proteins were visualized by Coomassie brilliant blue.


The Coomassie-stained gels were scanned using the Image Scanner (Amersham Biosciences Limited, Sweden) and the spots were detected, edited and annotated with ImageMas-ter 2D Platinum® software (Amersham Biosciences Limited, Sweden). The stained spots were selected, excised and dehydrated with 50 μL of acetonitrile for 15 minutes. To re-hydrate, the supernatant was then replaced with 25 µLof 25 mM NH4HCO3 for ten minutes. These steps of rehydra-tion followed by dehydration were repeated to give a total of three washes. Finally, the spots were dried for five minutes using a centrifugal evaporator (SpeedVac®,Thermo Scientific, USA).

In-Gel tryptic digestion

The dried spots were then re-suspended in 10 µLof 10 ng/µL trypsin in 25 mM NH4HCO3 and incubated for complete digestion at 37°C overnight. On completion, the gel was once again dehydrated with the addition of acetonitrile. Finally, the gel piece was removed and the supernatant was dried down in the SpeedVac® for 20 minutes.

Sample preparation for MS

An equal amount of tryptic-digested samples was mixed together with a matrix solution consisting of a-cyano-4-hydroxy cinnamic acid in acetonitrile acidified with tri-fluroacetic acid (1 mg/mL). Thereafter, 0.4 µL of this mixture was spotted on the slide and air-dried.

Mass spectrometry

MALDI-TOF mass spectra of peptide mixture were obtained on an Ettan MALDI-TOF-Pro mass spectrometer (Amersham Biosciences AB, Sweden) by a delayed ion source with nitrogen laser of 337 nm. The acceleration voltage was set to 20 kV with positive ion reflectron mode. The low mass rejection was activated. The instrument was calibrated externally with peptide samples of adrenocorticotropic hormone and angiotensin III that gave respective spectrum peaks at 897.531 and 2465.199.

Database searching

Proteins were identified via monoisotopic masses (as shown in the table found in Additional file 1) with the aid of the Internet search program MASCOT (http:// as well as ExPASy (http://www. For the MASCOT search, the search parameters were: NCBInr database, SwissProt and/or MSDB; species: Chordata vertebrates and relatives; missed cleavages: 1; enzyme: trypsin, tolerance: 1.0 Da and charge state: MH+. The parameters for the ExPASy search were: Swiss-Prot database; species: other vertebrata; missed cleavages: 1; enzyme: trypsin, ion mode: MH+.

Ethics statement

This study required no approval by any animal ethics committee as decided by the Animal Ethics Committee of University Malaya based on reasoning that the study dealt with venom milked from snakes of the wild rather than experimenting on them in the laboratory. All precautions were taken to ensure no harm were inflicted on the snakes by an expert snake handler.


Comparative analysis of 2-DE on various snake venoms

In the first-dimension isoelectric focusing, 18 cm IPG (pH 3-10) strips were used with the cup-loading technique, which was found to produce better results than sample application by in-gel rehydration. It was also ideal for separating the more basic proteins of the snake venoms when the loading cup is applied at the anodic site. Subsequently, the proteins were separated in the second dimension by 15% SDS-PAGE. The 2-DE images of the four snake venoms demonstrated different degrees of complexity in polypeptide constituents in general. The visual inspection of 2-DE maps showed notable differences in proteome profiles among the venoms of N. kaouthia, O. Hannah, B. fasciatus and C.rhodostoma (Figure 1). In particular, basic (high pI) and low-molecular-mass protein spots were found to be highly prominent in the venoms of N. kaouthiaand B. fasciatus. This is typical of venom of Elapidae origin, which is comprised mainly of neurotoxins. Nawarak et al. [13] had also demonstrated similar proteomic profiles in snake venoms from Elapidae families using multidimensional chromatographic approaches. Nevertheless, the proteomic profiles of O. hannah displayed certain degrees of disparity against those of elapids and showed similarities with those of C. rhodostoma,where the venom proteins were evenly dispersed across the pI and mass range.

Figure 1 Proteome maps of the snake venoms of (A) N. kaouthia,(B) O. hannah, (C) B. fasciatus,and (D) C. rhodostoma with IPG 3-10 (300 ng protein, 18 cm), 15% T, Coomassie blue staining showing the annotated spots of the four venoms. The spots were detected and annotated by using the software Image Master 2D Platinum. These protein spots were identified from the 2-DE gelstained by Coomassie blue, tryptic-digested, extracted and analyzed in duplicates per spot with MALDI-TOF MS in reflectron mode. 

Peptide mass fingerprinting (PMF) identification of protein spots from four snake venoms

Spots were selected and carefully identified from the 2-DE gel stained by Coomassie blue, tryptic-digested, extracted and analyzed in duplicates per spot with MALDI-TOF MS in reflectron mode. Identification by PMF on proteins isolated from 2-DE gels of the four venoms was performed by scanning the monoisotopic masses with two separate Internet search programs, MASCOT ( and ExPASy (previously located URL: In PMF, the profile of the unknown protein was compared with theoretical peptide libraries generated from sequences in the different databases. Identified proteins were chosen from either MASCOT or ExPASy, which yielded more numerous hits and higher sequence coverage. The latter search program was taken out of the public domain and continued as a licensed database until recently discontinued altogether.

A total of 113, 50, 26, and 115 spots were analyzed to obtain the venom protein compositions of N. kaouthia, O. hannah, B. fasciatus, andC. rhodostoma, respectively, but only the corresponding 34%, 86%, 54%, and 40% of these spots produced quality MALDI-TOF MS spectra. These spots were annotated and displayed in Figure 1. The remaining spots failed to give any spectra (not annotated within the figure). Respective totals of 16, 15, 6, and 26 spots linked to the database of N. kaouthia, O. hannah, B. fasciatus,andC. rhodostoma were identified by PMF (Table 1). Some proteins were mapped to more than one spot, for example, those of the cobra venom factor, phospholipase A2 isozymes and L-amino-acid oxidase. Although they produced relatively good quality spectra, a few spots from the 2-DE of the four venom species were unmatchable with proteins belonging to their respective venoms by either of the two database searches.

Table 1 Protein identification of annotated spots in venom proteomes ofN. kaouthia, O. hannah, B. fasciatus and C.rhodostoma  

Annotated spot Database Identified protein Accession number Hits SC,% Mw, kDa pI
N. kaouthia              
NN5 ExPASy Hemorrhagic metalloproteinase kaouthiagin P82942 6 13 44493 6.66
NN8 ExPASy Cobra venom factor beta chain Q91132 7 20 43574 5.26
NN9 MASCOT Cobra venom factor precursor AAA68989 10 6 184401 5.99
NN10 ExPASy Phospholipase A2 isozyme 2 P00597 4 39 13271 5.16
NN11 ExPASy Phospholipase A2 isozyme 2 P00597 7 67 13271 5.16
NN12 ExPASy Phospholipase A2 isozyme 1 P00596 3 35 13456 4.91
NN13 ExPASy Phospholipase A2 isozyme 2 P00597 4 41 13271 5.16
NN14 ExPASy Long neurotoxin 1 (neurotoxin 3) (alpha-cobratoxin) P01391 2 34 7831 8.59
NN15 ExPASy Muscarinic toxin-like protein 2 (MTLP-2) P82463 8 85 7299 8.18
NN16 ExPASy Thaicobrin P82885 6 77 12038 9.16
NN17 ExPASy Muscarinic toxin-like protein 3 (MTLP-3) P82464 2 45 7624 8.13
NN19 ExPASy Cytotoxin 1 P60305 2 28 6701 9.16
NN37 MASCOT Thaicobrin P82885 4 44 12030 9.17
NN45 ExPASy Phospholipase A2 isozyme 1 P00596 4 39 13456 4.91
NN46 ExPASy Phospholipase A2 isozyme 1 P00596 2 17 13456 4.91
NN52 ExPASy Cobra venom factor beta chain Q91132 4 11 43574 5.26
O. hannah              
KC5 ExPASy Phospholipase A2 Q9DF56 2 22 13931 4.83
KC6 ExPASy Phospholipase A2, acidic 2 Q9DF33 4 33 13191 4.41
KC9 ExPASy Phospholipase A2, acidic 2 Q9DF33 4 44 13191 4.41
KC10 ExPASy Phospholipase A2, acidic 2 Q9DF33 3 19 13190 4.42
KC18 ExPASy Ohanin P83234 5 57 11952 9.57
KC20 ExPASy Trypsin and chymotrypsim bi-functional serine protease inhibitor B6RLX2 5 86 6346 8.59
KC23 ExPASy Long neurotoxin 1 (neurotoxin A) P01387 2 47 8106 8.04
KC24 MASCOT Thioredoxin protein Q98TX1 3 38 11995 5.30
KC25 ExPASy Long neurotoxin OH-17 Q53B54 4 50 8037 8.34
KC26 ExPASy Long neurotoxin OH-55 Q53B58 7 93 7919 8.34
KC27 ExPASy Long neurotoxin 4 P80156 3 36 8014 8.05
KC32 ExPASy Muscarinic toxin-like protein 3 homolog A8N286 2 22 7542 7.44
KC33 ExPASy Long neurotoxin OH-55 Q53B58 2 42 7919 8.34
KC37 ExPASy Weak toxin DE-1 P01412 2 32 7027 5.49
KC50 ExPASy Complement-depleting factor ABN72543 9 6 184237 6.12
B. fasciatus              
BF1 ExPASy Phospholipase A2 homolog P29601 3 39 13104 4.37
BF2 ExPASy Phospholipase A2 KBf-grIB P0C551 3 26 14157 4.78
BF4 ExPASy Phospholipase A2 KBf-grIB P0C551 3 26 14157 4.78
BF7 ExPASy Phospholipase A2 homolog P29601 2 19 13104 4.37
BF9 ExPASy Phospholipase A2 13 P00627 3 71 3704 8.91
BF15 ExPASy Phospholipase A2 isozyme 6 P00627 2 25 13066 7.94
C. rhodostoma              
CR1 ExPASy Phospholipase A2 H1E6 Q9PVF2 8 48 13919 5.51
CR2 ExPASy Rhodocetin alpha subunit P81397 8 67 15962 5.16
CR5 ExPASy Phospholipase A2 W6D49 Q9PVF4 10 40 13689 8.34
CR6 ExPASy Phospholipase A2 W6D49 Q9PVF4 11 40 13689 8.34
CR14 ExPASy Disintegrin rhodostomin P30403 8 93 7330 6.70
CR15 ExPASy Rhodocytin subunit beta Q9I840 6 69 14369 7.08
CR16 ExPASy Rhodocytin subunit beta Q9I840 6 69 14369 7.08
CR17 ExPASy Metalloproteinase kistomin P0CB14 2 9 25846 6.41
CR18 ExPASy Metalloproteinase kistomin P0CB14 2 9 25846 6.41
CR19 ExPASy Halystase P81176 2 14 26483 6.70
CR21 MASCOT L-amino acid oxidase AJ271725 7 22 58184 6.05
CR22 MASCOT L-amino acid oxidase AJ271725 15 31 58184 6.05
CR23 ExPASy L-amino acid oxidase P81382 12 26 56228 6.04
CR25 ExPASy Ancrod (EC (venombin A) (protein C activator) P26324 7 27 26571 8.59
CR27 ExPASy Ancrod (EC (venombin A) (protein C activator) P26324 9 27 26571 8.59
CR28 MASCOT Venombin A (EC S20407 5 16 26553 8.61
    1 [validated]          
CR29 MASCOT Venombin A (EC S20407 4 16 26553 8.61
    1 [validated]          
CR30 MASCOT Ancrod- ike prote n CAA01524 3 10 25213 8.44
CR31 MASCOT Ancrod- ike prote n CAA01524 4 14 25213 8.44
CR32 MASCOT Ancrod- ike prote n CAA01524 4 14 25213 8.44
CR33 MASCOT Ancrod- ike prote n CAA01524 3 10 25213 8.44
CR34 MASCOT Ancrod- ike prote n CAA01524 14 4 25213 8.44
CR39 MASCOT L-amino acid oxidase AJ271725 8 21 58184 6.05
CR40 MASCOT Ancrod-like protein CAA01524 4 13 29314 8.54
CR41 ExPASy Ancrod [precursor] P47797 4 13 26461 8.53
CR43 ExPASy Metalloproteinase kistomin P0CB14 2 9 25846 6.41


In this study, the 2-DE of the various snake venoms displayed prominent vertical bands that hampered the identification of bioactive proteins. Similar bands were also observed by other researchers. For instance, Marshall and Williams [14] as well as Saravia et al. [15] reported similar findings in their works onCrotalus and Bothrops asper snake venoms, respectively.

As expected, the 2-DE images from the venoms of the four snake species demonstrated the complexity of polypeptide constituents and the known fact that the composition of snake venoms is 70 to 90% proteins [16]. The 2-DE of the four species showed obvious variations in protein map patterns. The distinctive protein maps obtained in this study may enable species identification, which is of clinical importance. The characteristic protein map of O.hannah, which displayed dissimilarities in relation to the other two elapids, exemplified the significance of this purpose. The 2-DE venom proteome profile of O. hannah displayed numerous protein spots at the higher molecular mass region similar to the viper rather than the other two elapids. This finding is substantiated by reports from Ohsaka [17] describing the exceptional existence of hemorrhagic activity provoked by O. hannah venom similar to that exerted by Viperid venoms while none of the Elapidae venoms exhibits similar hemorrhagic activity. The hemorrhagic activity of the major hemorrhagin, known as hannah toxin in O. hannah,was first demonstrated by Tan and Saifuddin [18] in rabbits. Further investigation may enable potential species-specific molecular markers to be identified or detected under different gel conditions, similar to bio-markers for the purpose of species identification or disease specification (e.g. in prognosis/diagnosis of various cancers). A study by Guercio et al. [19] had also postulated the potential of differential analyses of snake venom proteomes on the development of ontogenetic molecular markers via the identification of group-specific proteins.

To assess the venoms’ proteomics profiles, the combination of 2-DE with MALDI-TOF was used. Our study, unlike that done by Li et al. [2], matched the venom peptide masses of the particular snake species to their corresponding protein databases, found in the Taxonomy Browser. The Taxonomy Browser contained in the Entrez database ( provided the total number of proteins available for matching for each of the four snake venoms. The respective numbers of known proteins available as of October 2013 were 157 forN. kaouthia, 192 for O. hannah, 130 forB. fasciatus and 84 for C. rhodostoma. The protein database was constructed based on the sequence data from the translated coding regions from DNA sequences in GenBank, EMBL, and DDBJ as well as protein sequences submitted to Protein Information Resource (PIR), SWISS-PROT, Protein Research Foundation (PRF), and Protein Data Bank (PDB) (sequences from solved structures). It was obvious that the database was incomplete for snake venom matching, compared with 784,406 proteins available for Homo sapiens(human), and 123,173 for Bos taurus (cattle) proteins. Nevertheless, the snake venom protein database is still of greater value than those of some other venomous species such as Chironex yamaguchii (sea wasp) with only two proteins, Hadrurus aztecus (scorpion) with one, and Dolomedes plantarius (spider) with none, to name a few, for matching.

A closer examination of the snake-venom-protein database disclosed the following information: some of the proteins were not found in the venom but were evidently found elsewhere in the snake’s body, for example, the nerve growth factor (located in the nervous system), NADH dehydrogenase and cytochrome b (located in mitochondria) and oocyte maturation factor (located in the reproductive system). Also, most of the venom proteins were precursor forms or polypeptide chains of the same protein, for example: phospholipase PLA2 precursor and chain A, crystal structure of L-amino acid oxi-dase. Based on these factors, therefore, the snake venom proteins available for matching in the database were, in fact, much more limited.

Nevertheless, even with these limitations, many important proteins were identified in the 2-DE of the 4 species. A total of 63 proteins were identified: C. rhodos-toma - 26, N. kaouthia - 16, O. hannah - 15 and B. fasciatus- 6. Venoms from snakes contain various types of toxins such as cardiotoxins and neurotoxins, biological factors that are anti-coagulant, anti-thrombotic, anti-platelet binding, as well as active enzymes including phospholipase, endo- and exonucleotidases, hyaluroni-dase, neuraminidase, protease and many others. Generally, the non-enzymatic protein or polypeptide toxins dominate the lethal actions of elapids (e.g. cobra and krait) and sea snakes, whereas enzymes appear to play a more important role in the lethality of viperid (viper) and crotalid (pit viper) venoms [16].

In the present study, the phospholipase A2 (PLA2) group of enzymes was identified in all four species. At least one of these enzyme types was identified in each of the four species studied (Table 1). This finding is not surprising given that extensive studies on venom have demonstrated an accelerated natural selection force that drives the evolution of a multitude of extremely potent snake toxins from an ancestral PLA2 with digestive function [20,21]. Hundreds of species of venomous snakes of the families Elapidae and Viperidae were shown to have evolved a wide variety of venoms that contain varying proportions of toxins endowed with PLA2 activity, characterized by their neurotoxicity, myotoxicity, as well as anticoagulant and edema-inducing properties [21-23]. Hence, in snake venom, PLA2 enzymes, in addition to their possible role in digesting the prey, exhibit a wide variety of pharmacological effects through interfering with normal physiological processes [24]. It is well known that some of the most toxic and potent pharmacologically active components of snake venoms are either PLA2 enzymes or their protein complexes. For example, all known presynaptic neurotoxins from snake venom are PLA2 enzymes or contain at least one PLA2 as an integral part [25,26]. PLA2 myotoxins are more potent and act faster than their non-enzymatic counterparts [27].

PMF using MS also allowed the identification of long neurotoxins in both the cobra species studied. Unlike presynaptic beta-neurotoxins that exhibit varying PLA2 activities, these long neurotoxins are classified as alpha-neurotoxins that affect the post-synaptic membrane [28]. Post-synaptic neurotoxins have been identified only in venoms from the families Elapidae and Hydrophiidae (sea snakes). They are nicotinic receptor antagonists on the skeletal muscle and display different binding kinetics and affinity for subtypes of nicotinic receptors [29]. Other significant neuro-toxins, such as the muscarinic toxin-like proteins (MTLP), including ohanin and thaicobrin, were also identified in the cobra venoms.

Rhodocetin, another important protein identified in C. rhodostomavenom, is a Ca2+-dependent lectin-related protein (CLP) that is a potent platelet aggregation inhibitor induced by collagen. It is a prime example of a CLP dimer, in which the two subunits are held together by non-covalent interactions and act synergistically to elicit the biological activity, affecting platelet aggregation and blood coagulation, important in cellular thrombosis and non-cellular processes in homeostasis [30,31]. This protein was also demonstrated to antagonize stromal tumor invasion in vitro and other a2β1 integrin-mediated cell functions [32]. The proteomic approach applied in the present study also successfully identified a significant number of peptidases, namely zinc metalloproteinase or disintegrin, ancrod or venombin A, and L-amino-acid oxidases which display the well-documented hemotoxic properties of the viper’s venom. Disintegrin exhibits hemorrhagic activities by binding to the glycoprotein IIb-IIIa receptor on the platelet surface, thus inhibiting fibrinogen interaction with platelet receptors while L-amino-acid oxidases exert hemorrhagic effects by catalyzing oxidative deamination of hydrophobic and aromatic L-amino acids [33-36]. L-amino-acid oxidases have also recently been shown to display antibacterial properties [37]. On the other hand, ancrod is a thrombin-like serine protease that selectively cleaves the fibrinopeptides, resulting in aberrant fibrinogen that is unable to form dispersible blood clots [38].

Despite the identification of major proteins in the four snake species, a large number of spots from the 2-DE were unidentifiable with their respective snake venom protei ns even though the spots displayed high-quality MALDI-TOF-MS spectra. This was similar to the finding of another research group who identified proteins in two types of snake venoms: Naja naja atra and Agkistro-don halys [2]. In their study, only 50% of the spots were confirmed to have venom properties from approximately 80% of 2-DE gel spots displaying high-quality MALDI- TOF-MS spectra. As mentioned earlier, this was due to the unavailability of a full protein database or the result of post-translational modification (PTM). PTM of venomous proteins is a common phenomenon in snake venoms. Of a number of mechanisms inducing chemical modification of protein, glycosylation is one of the most frequently found Li et al. [2]. For instance, different degrees of glycosylation were discovered in the snake venom toxins of Crotalus atroxand Bothrops jararaca, using the fluorescent glycoprotein specific stain, Pro-Q-Emerald [39]. Given that the database for snake venoms is still developing, it is worth noting that easier identification remains possible in the future. This is evident when one compares the number of known proteins dating back to October 2005 (67 for N. kaouthia, 78 for O. hannah, 34 for B. fasciatus and 60 for C. rhodostoma)to the most recent Entrez protein database. Among these the protein database of B. fasciatusshows the most promising development, an augmentation of approximately 380%, while those of O. hannah increased by 125%, N. kaouthia by 235%, and C. rhodostoma by 140%.

With the comprehensive cataloguing of venom toxins, the characterization of species-specific venom proteome is therefore greatly facilitated when studying the patho-physiological effects arising from species-specific snakebites. For instance, the sequential, comparative 2-DE analysis of in vivo and in vitro effects of venom on specific plasma proteins from a patient bitten by a rattlesnake has demonstrated the pathological relationship between the snake toxins and the injury-related physiological alterations [40]. The application of proteomic tools by Escalante et al. [41] on wound exudates also revealed the tissue-damaging mechanisms of different snake venom toxins.


The 2-DE map of these venoms will play a vital role in the purification of their proteins by utilizing the 2-DE-guid purification applications as described by Tang et al. [42].


The authors would like to thank University of Malaya for providing the proteomic instrumentation to complete this study.


Lim BL: Poisonous snakes of Peninsular Malaysia. 3rd Revised edition. Malaysian Nature Society: Kuala Lumpur; 1991. [ Links ]

Li S, Wang J, Zhang X, Ren Y, Wang N, Zhao K, Chen X, Zhao C, Li X, Shao J, Yin J, West MB, Xu N, Liu S: Proteomic characterization of two snake venoms: Naja naja atra and Agkistrodon halys. Biochem J 2004, 384(Pt 1):119-127. [ Links ]

3.  Fox JW, Serrano SM: Exploring snake venom proteomes: multifaceted analyses for complex toxin mixtures. Proteomics 2008, 8(4):909-920. [ Links ]

4.  Lee CY: Chemistry and pharmacology of polypeptide toxins in snake venoms. Annu Rev Pharmacol 1972, 12:265-281. [ Links ]

5.  Fox JW, Kamiguti AS, Theakston RDG, Shannon JD, Stefansson B, Serrano SMT, Camargo ACM, Sherman N: Role of discovery science in toxinology: examples in venom proteomics. In Perspectives in molecular toxinology.Edited by Menez A. Chichester: John Wiley & Sons; 2002:97-106. [ Links ]

6.  Creer S, Malhotra A, Thorpe RS, Stocklin R, Favreau PS, Hao Chou WS: Genetic and ecological correlates of intraspecific variation in pitviper venom composition detected using matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF-MS) and isoelectric focusing. J Mol Evol2003, 56(3):317-329. [ Links ]

7.  Nawarak J, Phutrakul S, Chen ST: Analysis of lectin-bound glycoproteins in snake venom from the Elapidae and Viperidae families. J Proteome Res 2004, 3(3):383-392. [ Links ]

Juarez P, Sanz L, Calvete JJ: Snake venomics: characterization of protein families in Sistrurus barbouri venom by cysteine mapping, N-terminal sequencing, and tandem mass spectrometry analysis. Proteomics 2004, 4(2):327-338. [ Links ]

Toyama OD, Boschero CA, Martins AM, Fonteles CM, Monteiro SH, Toyama MH: Structure-function relationship of new crotamine isoform from the Crotalus durissus cascavella. Protein J 2005, 24(1):9-19. [ Links ]

10.  Oliveira DG, Toyama MH, Novello JC, Beriam LO, Marangoni S: Structural and functional characterization of basic PLA2 isolated from Crotalus durissus terrificus venom. J Protein Chem 2002, 21 (3):161 -168. [ Links ]

11.  Vejayan J, Shin Yee L, Ponnudurai G, Ambu S, Ibrahim H: Protein profile analysis of Malaysian snake venoms by two-dimensional gel electrophoresis. J Venom Anim Toxins Incl Trop Dis 2010, 16(4):623-630. [ Links ]

12.  Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem 1976, 72:248-254. [ Links ]

13.  Nawarak J, Sinchaikul S, Wu CY, Liau MY, Phutrakul S, Chen ST: Proteomics of snake venoms from Elapidae and Viperidae families by multidimensional chromatographic methods. Electrophoresis 2003, 24(16):2838-2854. [ Links ]

14.  Marshall T, Williams KM: Analysis of snake venoms by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and two-dimensional electrophoresis.Appl Theor Electrophor 1994, 4(1):25-31. [ Links ]

15.  Saravia P, Rojas E, Escalante T, Arce V, Chaves E, Velasquez R, Lomonte B, Rojas G, Gutierrez JM: The venom of Bothrops asper from Guatemala: toxic activities and neutralization by antivenoms. Toxicon2001, 39(2-3):401 -405. [ Links ]

16.  Tu AT: Venoms: chemistry and molecular biology. New York: John Wiley & Sons; 1977. [ Links ]

17.  Ohsaka A: Hemorrhagic, necrotizing and edema-forming effects of snake venoms. In Handbook of Experimental Pharmacology, Volume 52. Edited by Lee CY. Berlin: Springer; 1979:481 -546. [ Links ]

18.  Tan NH, Saifuddin MN: Isolation and characterization of a hemorrhagin from the venom of Ophiophagus hannah (king cobra). Toxicon1990, 28(4):385-392. [ Links ]

Guercio RAP, Shevchenko A, Shevchenko A, Lopez-Lozano JL, Paba J, Sousa MV, Ricart CAO: Ontogenetic variations in the venom proteome of the Amazonian snake Bothrops atrox. Proteome Sci 2006, 4:1 -14. [ Links ]

20.  Ogawa T, Nakashima K-I, Nobuhisa I, Deshimaru M, Shimohigashi Y, Fukumaki Y, Sakaki Y, Hattori S, Ohno M: Accelerated evolution of snake venom phospholipase A2 isozymes for acquisition of diverse physiological functions.Toxicon 1996, 34(11 -12):1229-1236. [ Links ]

21.  Montecucco C, Gutierrez JM, Lomonte B: Cellular pathology induced by snake venom phospholipase A2 myotoxins and neurotoxins: common aspects of their mechanisms of action. Cell Mol Life Sci 2008, 65(18):2897-2912. [ Links ]

22.  Boffa GA, Boffa MC, Winchenne JJ: A phospholipase A2 with anticoagulant activity. I. Isolation from Vipera berus venom and properties.Biochim Biophys Acta 1976, 429(3):839-852. [ Links ]

23.  Vishwanath BS, Kini RM, Gowda TV: Characterization of three edema-inducing phospholipase A2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid. Toxicon1987, 25(5):501 -515. [ Links ]

24.  Kini RM: Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon 2003, 42(8):827-840. [ Links ]

25.  Bon C: Multicomponent neurotoxic phospholipases A2. In Venom phospholipase A2 enzymes: structure, function and mechanism. Edited by Kini RM. Chichester: John Wiley & Sons; 1997:269-285. [ Links ]

26.  Fletcher JE, Rosenberg P: The cellular effects and mechanisms of action of presynaptically acting phospholipase A2 enzymes. In Venom phospholipase A2 enzymes: structure, function and mechanism. Edited by Kini RM. Chichester: John Wiley & Sons; 1997:413-454. [ Links ]

27.  Gubensek F, Kriaj I, Pungerar J: Monomeric phospholipase A2 neurotoxins. In Venom phospholipase A2 enzymes: structure, function and mechanism. Edited by Kini RM. Chichester: John Wiley & Sons; 1997:245-268. [ Links ]

28.  Lewis RL, Gutmann L: Snake venoms and the neuromuscular junction.Semin Neurol 2004, 24(2):175-179. [ Links ]

29.  Hodgson WC, Wickramaratna JC: In vitro neuromuscular activity of snake venoms. Clin Exp Pharmacol Physiol 2002, 29(9):807-814. [ Links ]

30.  Kornalik F: The influence of snake venom proteins on blood coagulation. In Snake Toxin. Edited by Harvey AL. New York: Pergamon Press; 1991:323-383. [ Links ]

31.  Wang R, Kini RM, Chung MC: Rhodocetin, a novel platelet aggregation inhibitor from the venom of Calloselasma rhodostoma (Malayan pit viper): synergistic and noncovalent interaction between its subunits.Biochemistry 1999, 38(23):7584-7593. [ Links ]

32.  Eble JA, Niland S, Dennes A, Schmidt-Hederich A, Bruckner P, Brunner G: Rhodocetin antagonizes stromal tumor invasion in vitro and other alpha2beta1 integrin-mediated cell functions. Matrix Biol 2002, 21(7):547-558. [ Links ]

33.  Dennis MS, Henzel WJ, Pitti RM, Lipari MT, Napier MA, Deisher TA, Bunting S, Lazarus RA: Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet aggregation inhibitors.Proc Natl Acad Sci USA 1990, 87(7):2471 -2475. [ Links ]

34.  Gould RJ, Polokoff MA, Friedman PA, Huang TF, Holt JC, Cook JJ, Niewiarowski S: Disintegrins: a family of integrin inhibitory proteins from viper venoms. ProcSocExp Biol Med 1990, 195(2):168-171. [ Links ]

Au LC, Lin SB, Chou JS, Teh GW, Chang KJ, Shih CM: Molecular cloning and sequence analysis of the cDNA for ancrod, a thrombin-like enzyme from the venom of Calloselasma rhodostoma. Biochem J 1993, 294(Pt 2):387-390. [ Links ]

36.  MacHeroux P, Seth O, Bollschweiler C, Schwarz M, Kurfurst M, Au LC, Ghisla S: L-amino-acid oxidase from the Malayan pit viper Calloselasma rhodostoma. Comparative sequence analysis and characterization of active and inactive forms of the enzyme. Eur J Biochem 2001, 268(6):1679-1686. [ Links ]

37.  Tonismagi K, Samel M, Trummal K, Ronnholm G, Siigur J, Kalkkinen N, Siigur E: L-amino acid oxidase from Vipera lebetina venom: isolation, characterization, effects on platelets and bacteria. Toxicon2006, 48(2):227-237. [ Links ]

38.  Au LC, Chou JS, Chang KJ, The GW, Lin SB: Nucleotide sequence ofa full-length cDNA encoding a common precursor of platelet aggregation inhibitor and hemorrhagic protein from Calloselasma rhodostoma venom. Biochim Biophys Acta 1993, 1173(2):243-245. [ Links ]

39.  Serrano SMT, Shannon JD, Wang D, Camargo ACM, Fox JW: A multifaceted analysis of viperid snake venoms by two-dimensional gel electrophoresis: an approach to understanding venom proteomics. Proteomics 2005, 5(2):501 -510. [ Links ]

40.  Bagley EA, Lonberg-Holm K, Pandya BV, Budzynski AZ: Two-dimensional gel electrophoretic analysis of plasma proteins from a patient bitten by a rattlesnake. Electrophoresis 1983, 4(3):238-241. [ Links ]

41.  Escalante T, Rucavado A, Pinto AFM, Terra RMS, Gutierrez JM, Fox JW: Wound exudate as a proteomic window to reveal different mechanisms of tissue damage by snake venom toxins. J Proteome Res 2009, 8(11):5120-5131. [ Links ]

42.  Tang MS, Vejayan J, Ibrahim H: The concept of two-dimensional electrophoresis-guided purification proven by isolation of rhodocetin from Calloselasma rhodostoma (Malayan pit viper). J Venom Anim Toxins Incl Trop Dis 2011, 17(4):442-450. [ Links ]

1Faculty of Industrial Sciences and Technology, University Malaysia Pahang, Lebuhraya Tun Razak, Kuantan, Pahang Darul Makmur 26300, Malaysia Fulllist of author information is available at the end of the article

Received: October 23, 2013; Accepted: February 17, 2014; Revised: March 4, 2014


Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

All authors contributed equally to the present work. All authors read and approved the final manuscript

Creative Commons License This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.